Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

25.19 +0.15 (+0.60%)

Official Closing Price Updated: 7:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

99 100 Next >

Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead ↗

October 08, 2025

These biotechs could finally come into their own by the end of the decade.

Via The Motley Fool

Topics Government World Trade

Why AbbVie and Johnson & Johnson Could Outperform Pfizer ↗

October 08, 2025

Pfizer stock is moving higher after being named part of the TrumpRx platform; but two other biopharma companies may offer better long-term growth potential

Via MarketBeat

Eli Lilly Stock Eases After-Hours: Ex-FDA Official Ejected By RFK Jr. Joins Firm — Will Investors Warm Up? ↗

October 07, 2025

Investors reacted to the company’s leadership shake-up and new data from its ulcerative colitis therapy Omvoh showing sustained remission over four years.

Via Stocktwits

Topics Government

Curious about the most active S&P500 stocks in today's session? ↗

October 07, 2025

Explore the S&P500 index on Tuesday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.

Via Chartmill

Viking Therapeutics Ignites Retail-Trader Frenzy Amid Deal Speculation, Upcoming Trial Catalysts ↗

October 06, 2025

Via Stocktwits

Why QuidelOrtho (QDEL) Stock Is Down Today

October 07, 2025

Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 4.4% in the morning session after Citigroup analyst Patrick Donnelly downgraded the stock to 'Neutral' from 'Buy' and lowered the...

Via StockStory

Topics World Trade

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)

October 07, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

The No. 1 Investing Mistake to Avoid As Washington Grinds to a Halt ↗

October 07, 2025

Washington has shut down -- but don't fall into a panic, because these things don't last.

Via The Motley Fool

Why The Pfizer-Trump Pharma Deal Is A Win For Branded Pharma, But Not For Consumers ↗

October 07, 2025

The deal on drug prices between the US Administration and Pfizer will leave the margins of innovative pharma companies intact.

Via Talk Markets

Down 50%, Should You Buy the Dip on Pfizer? ↗

October 07, 2025

Pfizer's stock price is down materially from its 2021 highs, but it is also up notably from its April 2025 lows.

Via The Motley Fool

Topics Intellectual Property

TrumpRx Brings Pfizer Into the Green—Is It a Buy? ↗

October 07, 2025

Pfizer entered into a major agreement with the U.S. government to produce more affordable drugs for Americans. However, the stock’s outlook is still cloudy.

Via MarketBeat

Topics Government

Worried About Tariffs? 2 Safe Haven Stocks to Buy on the Dip With $500 ↗

October 07, 2025

Tariffs aren't likely to weigh on growth at these companies.

Via The Motley Fool

Topics Government Stocks World Trade

Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal ↗

October 06, 2025

Eli Lilly just got great news, courtesy of Pfizer and Trump, leading shares to their highest level in five months. Its rally may just be getting started.

Via MarketBeat

Topics Government World Trade

Divergent Paths: Real Estate Stumbles While Healthcare Shines Amidst S&P 500's Record Ascent

October 06, 2025

As the S&P 500 and Nasdaq Composite continue their relentless climb to uncharted record highs in early October 2025, a fascinating and somewhat contradictory narrative is unfolding within the...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

U.S. Labor Market Stalls: Moody's Reports 'Essentially No Job Growth' Amidst Government Shutdown, Raising Recession Fears

October 06, 2025

Washington D.C., October 6, 2025 – The American labor market appears to have hit a significant speed bump, with Moody's Analytics reporting "essentially no job growth" for the U.S. in September 2025....

Via MarketMinute

Topics Artificial Intelligence Credit Cards Economy

From Defense To Pharma To Energy: Dividend Opportunities Across Sectors ↗

October 06, 2025

Lockheed’s defense backlog, Pfizer’s biotech expansion, and Schlumberger’s energy contracts make for safe and potentially lucrative dividend plays heading into year-end.

Via Talk Markets

Amgen To Offer Cholesterol Drug At 60% Discount As Trump Administration's Call To Lower Drug Prices ↗

October 06, 2025

Amgen launches AmgenNow, offering Repatha at $239 per month, expanding direct access for U.S. patients with no insurer restrictions.

Via Benzinga

Topics Government

Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giants ↗

October 06, 2025

Trump’s drug price plan drove a Pfizer rally, leaves Eli Lilly buffered by U.S. investments, and could boost JNJ if it secures similar tariff relief.

Via MarketBeat

Topics Government Supply Chain World Trade

Which S&P500 stocks are the most active on Monday? ↗

October 06, 2025

Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Monday and uncover the stocks that are leading the way in terms of trading volume and market...

Via Chartmill

10 Health Care Stocks Whale Activity In Today's Session ↗

October 06, 2025

Via Benzinga

U.S. Tariff Barrage Rocks Global Markets: A Deep Dive into Trade Policy's Tremors

October 06, 2025

The global financial landscape has been significantly reshaped by a relentless wave of U.S. tariff announcements throughout 2025, sending shockwaves across major indices, currency markets, and...

Via MarketMinute

Topics Economy Government Law Enforcement

AI Unlocks Secrets of Intrinsically Disordered Proteins: A Paradigm Shift in Biomedical Design

October 06, 2025

A groundbreaking advancement in artificial intelligence has opened new frontiers in understanding and designing intrinsically disordered proteins (IDPs), a class of biomolecules previously considered...

Via TokenRing AI

Topics Artificial Intelligence Derivatives

Great News for Pfizer Stock Investors ↗

October 06, 2025

Pharma stocks have been under pressure from the administration in 2025.

Via The Motley Fool

Topics World Trade

3 Reasons to Buy Pfizer Stock Now ↗

October 06, 2025

After years of underperformance, the future is looking brighter for the drugmaker.

Via The Motley Fool

3 Dirt Cheap Stocks to Buy in a Market Priced for Perfection ↗

October 05, 2025

Bargains can be found even when the stock market is arguably frothy.

Via The Motley Fool

Topics Economy Government Intellectual Property

Can Pfizer's Stock Break This Disappointing Streak? ↗

October 05, 2025

Pfizer's stock has been struggling for multiple years, and even a low valuation hasn't made it an enticing option for many investors.

Via The Motley Fool

Topics Government Intellectual Property World Trade

Want $7,800 in Annual Passive Income? Invest $100,000 in These 3 Ultra-High-Yield Dividend Stocks. ↗

October 05, 2025

These stocks can make your money work for you.

Via The Motley Fool

Topics Energy Initial Public Offering

European Markets Soar: Healthcare and Mining Lead the Charge Amidst Dovish Fed and Robust Fundamentals

October 04, 2025

European financial markets are currently experiencing a period of remarkable strength, with major indices reaching or nearing all-time highs in early October 2025. This significant rally is largely...

Via MarketMinute

Topics Artificial Intelligence Economy Electric Vehicles

European Equities Soar to Six-Month Highs as Rate Cut Hopes and Sectoral Strength Drive Rally

October 04, 2025

The European stock market has concluded its strongest week in five to six months, with the pan-European STOXX 600 index climbing a significant 2.8% by the week ending October 3, 2025. This robust...

Via MarketMinute

Topics Economy World Trade

Pfizer’s AI Revolution: A New Era for Drug Discovery and Pharmaceutical Innovation

October 04, 2025

In a groundbreaking strategic pivot, pharmaceutical giant Pfizer (NYSE: PFE) is aggressively integrating artificial intelligence (AI), machine learning (ML), and advanced data science across its entire...

Via TokenRing AI

Topics Artificial Intelligence Economy

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Pfizer (NY:PFE)

All News about Pfizer

Starting at $3.75/week.

Subscribe Today